The mob that Takeda bought out in the EU were in the process of doing a Sepsis trial, seemed to be a quite a bit of academic support for it at the time. The trial went by the wayside partly because that was not what Takeda were after and the continuing funding for the trial parts was not in one piece, needed reapplying for if I recall correctly.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-17560
-
- There are more pages in this discussion • 686 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.25 |
Change
0.035(2.89%) |
Mkt cap ! $1.421B |
Open | High | Low | Value | Volume |
$1.21 | $1.25 | $1.18 | $4.096M | 3.347M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22000 | $1.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.25 | 36989 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22000 | 1.240 |
2 | 45159 | 1.235 |
4 | 42275 | 1.230 |
1 | 15746 | 1.225 |
5 | 56349 | 1.220 |
Price($) | Vol. | No. |
---|---|---|
1.245 | 36989 | 4 |
1.250 | 118007 | 15 |
1.255 | 236249 | 7 |
1.260 | 440345 | 9 |
1.265 | 67045 | 4 |
Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |